Eversept Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4M Buy
114,199
+84,687
+287% +$15.6M 1.11% 25
2026
Q1
$5.57M Buy
+29,512
New +$6.22M 0.29% 57
2024
Q2
Sell
-175,631
Closed -$18.5M 80
2024
Q1
$18.5M Sell
175,631
-11,634
-6% -$1.05M 1.23% 18
2023
Q4
$14.2M Buy
+187,265
New +$11.9M 1.24% 21
2023
Q2
Sell
-141,892
Closed -$8.43M 76
2023
Q1
$8.43M Sell
141,892
-112,694
-44% -$6.26M 0.59% 32
2022
Q4
$12.4M Buy
+254,586
New +$11.8M 1.09% 21

Other funds holding THC

Eversept Partners's THC Position: Q2 2026 in Review

Eversept Partners increased its Tenet Healthcare (THC) stake by 287% in Q2 2026, buying an estimated $15.6M and bringing the position to 114,199 shares worth $21.4M. The position accounts for 1.11% of the portfolio, ranked #25.

Eversept Partners first reported a position in THC in Q4 2022 and has held it in 6 quarters since. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Eversept Partners held 114,199 shares of Tenet Healthcare worth $21.4M as of Q2 2026.
  • Eversept Partners bought 84,687 Tenet Healthcare shares in Q2 2026, an estimated $15.6M.
  • Tenet Healthcare made up 1.11% of Eversept Partners's portfolio in Q2 2026, its #25 holding.
  • Eversept Partners first reported a position in Tenet Healthcare in Q4 2022 and has held it in 6 quarters since.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.